What ophthalmic drops are appropriate for a red, irritated eye?

Treatment for Red, Irritated Eye

For a red, irritated eye, first determine the underlying cause: if allergic symptoms (itching) predominate, use topical antihistamines (olopatadine, ketotifen) or mast cell stabilizers; if mild bacterial conjunctivitis with purulent discharge, use broad-spectrum topical antibiotics for 5-7 days; if simple cosmetic redness from minor irritation, use OTC decongestants like brimonidine 0.025% (preferred over tetrahydrozoline/naphazoline due to less rebound); however, severe pain, photophobia, decreased vision, or trauma require immediate ophthalmology referral.

Algorithmic Approach to Eye Drop Selection

Step 1: Rule Out Emergencies

Before selecting any eye drops, identify red flags that require immediate ophthalmology consultation 1:

• Severe ocular pain
• Significant photophobia
• Decreased vision
• History of ocular trauma

If any of these are present, do not treat empirically—refer immediately.

Step 2: Identify the Clinical Pattern

For Allergic Conjunctivitis (itching is the hallmark symptom):

• Topical antihistamines and mast cell stabilizers are first-line 2
• All agents reduce symptoms and signs when compared to placebo 2
• Options include: olopatadine, ketotifen, azelastine, emedastine, nedocromil sodium, or sodium cromoglycate 2
• These are safe and well-tolerated with no serious adverse events reported 2
• Antihistamine eye drops work by blocking histamine H1 receptors, while mast cell stabilizers prevent histamine release 3, 2
• When possible, use preservative-free formulations to avoid disrupting the ocular surface 3

For Mild Bacterial Conjunctivitis (purulent discharge, minimal pain):

• This is usually self-limited in immunocompetent adults 4
• However, topical antibiotics provide earlier clinical and microbiological remission (days 2-5) 4
• Use a 5-7 day course of broad-spectrum topical antibiotic—choose the most convenient or least expensive option 4
• No clinical evidence suggests superiority of any particular antibiotic 4
• Povidone-iodine 1.25% ophthalmic solution may be equally effective when antibiotic access is limited 4
• Advise return visit in 3-4 days if no improvement 4

For Moderate to Severe Bacterial Conjunctivitis (copious purulent discharge, pain, marked inflammation):

• Obtain conjunctival cultures and Gram stain, especially if gonococcal infection suspected 4
• Consider MRSA, which is increasingly common and resistant to many topical antibiotics 4
• May require compounded antibiotics like vancomycin based on culture results 4

For Simple Cosmetic Redness (minor irritation, no discharge or itching):

• OTC decongestants available: tetrahydrozoline 0.05%, naphazoline 0.012-0.03%, brimonidine 0.025% 5
• Brimonidine 0.025% is preferred because it's a selective α2-agonist with minimal tachyphylaxis and rare rebound redness 5
• Tetrahydrozoline (α1-agonist) and naphazoline (mixed α1/α2-agonist) are associated with loss of effectiveness and rebound redness with continued use 5
• All produce rapid vasoconstriction with minimal, mild, transient adverse events 5

Step 3: Common Pitfalls to Avoid

Don't miss gonococcal conjunctivitis:

• Requires systemic antibiotics, not just topical therapy 4
• Consider sexual abuse in children with gonococcal or Chlamydia infections 4
• Daily follow-up required until resolution 4

Don't overuse decongestants:

• α1-agonist decongestants cause tachyphylaxis and rebound redness 5
• If decongestants are needed chronically, the underlying cause needs investigation

Don't ignore treatment failure:

• Bacterial conjunctivitis should improve within 3-4 days 4
• Persistent symptoms warrant re-evaluation and possible culture

Nuances in the Evidence

The 2024 AAO guideline 4 provides the most authoritative framework, emphasizing that mild bacterial conjunctivitis is self-limited but antibiotics shorten morbidity. The Cochrane review 2 demonstrates that all topical antihistamines and mast cell stabilizers work for allergic conjunctivitis, but notes poor quality reporting and short-term data only (1-8 weeks). The research on decongestants 5 clearly distinguishes brimonidine's superior profile regarding rebound effects, making it the rational choice when cosmetic redness reduction is the goal.

The key clinical decision point is distinguishing between allergic (itching predominates), infectious (discharge predominates), and simple irritation (cosmetic redness only)—this determines which eye drop category to use.